Skip to main content
Log in

Warfarin Therapy for Giant Aneurysm Prevents Myocardial Infarction in Kawasaki Disease

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

We retrospectively investigated the effect of warfarin therapy in improving the clinical outcome of Kawasaki disease (KD) patients with giant coronary aneurysms (GAs). We followed 2350 KD patients from 1973 to 2004. The GAs (≥8 mm in diameter) were diagnosed by coronary angiography. Sixty-eight patients (54 males and 14 females) were retrospectively studied. Patients were divided into two groups. One group consisted of 19 patients with 33 branches treated with a combination of low-dose aspirin and warfarin (target international normalized ratio: 1.5 – 2.5 IU). The second group consisted of 49 patients with 102 branches treated with low-dose aspirin without warfarin. The incidence of myocardial infarction was significantly less in the combination therapy group than in patients treated with aspirin without warfarin (1 patient vs. 16 patients, p < 0.05). Sudden death occurred in seven patients taking aspirin without warfarin, but none of the patients receiving warfarin died. No major bleeding events occurred in either group. Combination therapy of warfarin with aspirin is associated with a decreased risk of myocardial infarction in KD patients with GAs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Andrew M, Marzinotto V, Brooker L, Adams M, Ginsberg J, Freedom R, Williams W (1994) Oral anticoagulation therapy in pediatric patients: a prospective study. Thromb Haemost 71:265–269

    PubMed  CAS  Google Scholar 

  2. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N (1982) Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol 49:1758–1766

    Article  PubMed  CAS  Google Scholar 

  3. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease: a 10 to 21 year follow-up study of 594 patients. Circulation 94:1379–1385

    PubMed  CAS  Google Scholar 

  4. Newburger JW, Takahashi M, Gerber MA, et al. (2004) Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation 110:2747–2771

    Article  PubMed  Google Scholar 

  5. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N (2005) Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J 69:265–272

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiro Ishii.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sugahara, Y., Ishii, M., Muta, H. et al. Warfarin Therapy for Giant Aneurysm Prevents Myocardial Infarction in Kawasaki Disease. Pediatr Cardiol 29, 398–401 (2008). https://doi.org/10.1007/s00246-007-9132-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-007-9132-9

Keywords

Navigation